Press Releases July 20, 2026 08:00 AM

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

MiMedx Group to announce Q2 2026 financial results with webcast conference call scheduled for July 29

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
MDXG

MiMedx Group, Inc., a Nasdaq-listed company specializing in advanced wound care and healing products, announced it will release its second quarter 2026 operating and financial results on July 29, 2026, followed by a webcast and conference call hosted by senior management.

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29
MDXG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Scheduled release of Q2 2026 operating and financial results on July 29, 2026.
  • Company specializes in products for wound care, burns, and surgical applications.
  • Conference call and webcast planned for investors to discuss results and business outlook.

MARIETTA, Ga., July 20, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2026 after the market close on Wednesday, July 29, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13761338

A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.

About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Contact:
Matt Notarianni
Investor Relations
470-304-7291
[email protected]


Risks

  • Dependence on successful product innovation and market adoption in the competitive wound care industry.
  • Potential uncertainties in financial performance due to healthcare sector dynamics and reimbursement policies.
  • Market reaction may be influenced by results not meeting investor expectations or guidance.

More from Press Releases

Zoom appoints Carlos Quaderi as Head of APAC to drive next phase of AI-powered growth Jul 20, 2026 Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress Jul 20, 2026 Columbia Financial, Inc. Announces Completion of Second Step Conversion and $1.7 Billion Stock Offering and Acquisition of Northfield Bancorp, Inc. Jul 20, 2026 Quantum BioPharma Announces Intention to Settle Debt Jul 20, 2026 AMR Resources Acquisition Corp Announces Closing of $260,000,000 Initial Public Offering, Including Partial Exercise of Underwriters’ Over-Allotment Option Jul 20, 2026